Similarities and differences between stakeholders’ opinions on using Health Technology Assessment (HTA) information across five European countries: results from the EQUIPT survey

Mostra el registre complet Registre parcial de l'ítem

• dc.contributor.author Vokó, Zoltán
• dc.contributor.author Cheung, Kei Long
• dc.contributor.author Józwiak-Hagymásy, Judit
• dc.contributor.author Wolfenstetter, Silke B.
• dc.contributor.author Jones, Teresa
• dc.contributor.author Muñoz, Celia
• dc.contributor.author Evers, Silvia M. A. A.
• dc.contributor.author Hiligsmann, Mickaël
• dc.contributor.author de Vries, Hein
• dc.contributor.author Pokhrel, Subhash
• dc.date.accessioned 2025-02-03T07:48:08Z
• dc.date.available 2025-02-03T07:48:08Z
• dc.date.issued 2016
• dc.description Includes supplementary materials for the online appendix.
• dc.description.abstract Background. The European-study on Quantifying Utility of Investment in Protection from Tobacco (EQUIPT) project aimed to study transferability of economic evidence by co-creating the Tobacco Return On Investment (ROI) tool, previously developed in the United Kingdom, for four sample countries (Germany, Hungary, Spain and the Netherlands). The EQUIPT tool provides policymakers and stakeholders with customized information about the economic and wider returns on the investment in evidence-based tobacco control, including smoking cessation interventions. A Stakeholder Interview Survey was developed to engage with the stakeholders in early phases of the development and country adaptation of the ROI tool. The survey assessed stakeholders’ information needs, awareness about underlying principles used in economic analyses, opinion about the importance, effectiveness and cost-effectiveness of tobacco control interventions, and willingness to use a Health Technology Assessment (HTA) tool such as the ROI tool. Methods. A cross sectional study using a mixed method approach was conducted among participating stakeholders in the sample countries and the United Kingdom. The individual questionnaire contained open-ended questions as well as single choice and 7- or 3-point Likert-scale questions. The results corresponding to the priority and needs assessment and to the awareness of stakeholders about underlying principles used in economic analysis are analysed by country and stakeholder categories. Results. Stakeholders considered it important that the decisions on the investments in tobacco control interventions should be supported by scientific evidence, including prevalence of smoking, cost of smoking, quality of life, mortality due to smoking, and effectiveness, cost-effectiveness and budget impact of smoking cessation interventions. The proposed ROI tool was required to provide this granularity of information. The majority of the stakeholders were aware of the general principles of economic analyses used in decision making contexts but they did not appear to have in-depth knowledge about specific technical details. Generally, stakeholders’ answers showed larger variability by country than by stakeholder category. Conclusions. Stakeholders across different European countries viewed the use of HTA evidence to be an important factor in their decision-making process. Further, they considered themselves to be capable of interpreting the results from a ROI tool and were highly motivated to use it.en
• dc.description.sponsorship The research leading to these results has received funding from the European Community’s Seventh Framework Programme under grant agreement No. 602270 (EQUIPT).en
• dc.format.mimetype application/pdf
• dc.identifier.citation Vokó Z, Cheung KL, Józwiak-Hagymásy J, Wolfenstetter SMAA, Jones T, Muñoz C, et al. Similarities and differences between stakeholders’ opinions on using Health Technology Assessment (HTA) information across five European countries: results from the EQUIPT survey. Health Res Policy Syst. 2016 Dec;14(1):38. DOI: 10.1186/s12961-016-0110-7
• dc.identifier.doi http://dx.doi.org/10.1186/s12961-016-0110-7
• dc.identifier.issn 1478-4505
• dc.identifier.uri http://hdl.handle.net/10230/69442
• dc.language.iso eng
• dc.publisher BioMed Central
• dc.relation.ispartof Health Research Policy and Systems. 2016 Dec;14(1):38
• dc.relation.isreferencedby http://dx.doi.org/10.6084/m9.figshare.c.3621473_D1.v1
• dc.relation.projectID info:eu-repo/grantAgreement/EC/FP7/602270
• dc.rights This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
• dc.rights.accessRights info:eu-repo/semantics/openAccess
• dc.rights.uri http://creativecommons.org/publicdomain/zero/1.0/
• dc.subject.keyword Smoking cessationen
• dc.subject.keyword EQUIPTen
• dc.subject.keyword Stakeholder engagementen
• dc.subject.keyword Return on investmenten
• dc.subject.keyword Transferability of economic evidenceen
• dc.title Similarities and differences between stakeholders’ opinions on using Health Technology Assessment (HTA) information across five European countries: results from the EQUIPT surveyen
• dc.type info:eu-repo/semantics/article
• dc.type.version info:eu-repo/semantics/publishedVersion